The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1488
ISSUE1488
February 15, 2016
Patiromer (Veltassa) for Hyperkalemia
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Patiromer (Veltassa) for Hyperkalemia
February 15, 2016 (Issue: 1488)
The FDA has approved patiromer (Veltassa –
Relypsa), an oral potassium binder, for treatment
of hyperkalemia. It is the first drug to be approved
for this indication since the cation-exchange resin
sodium polystyrene sulfonate (Kayexalate, and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.